Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William L Farrar

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
American Journal of Epidemiology|March 18, 2008
Re: "Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the women's health initiative (United States)"Nima Sharifi, William L Farrar
American Journal of Therapeutics|April 29, 2006
Androgen receptor as a therapeutic target for androgen independent prostate cancerNima Sharifi, William L Farrar
Medical Hypotheses|December 21, 2005
Perturbations in hypoxia detection: a shared link between hereditary and sporadic tumor formation?Nima Sharifi, William L Farrar
Molecular Interventions|August 12, 2008
Cancer stem cells: the seeds of metastasis?Elaine M Hurt, William L Farrar
Trends in Immunology|September 9, 2008
Cancer stem cells, CD200 and immunoevasionBrian T Kawasaki, William L Farrar
Epigenomics|November 30, 2011
Cancer stem cell epigenetics and chemoresistanceFrancesco Crea, Romano Danesi, William L Farrar
Biochemistry|April 7, 2004
Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic stateKiranam Chatti, William L Farrar, Roy J Duhé
Molecular Cancer|October 6, 2010
Clinical significance of Polycomb gene expression in brain tumorsFrancesco Crea, Elaine M Hurt, William L Farrar
Cancer Chemotherapy and Pharmacology|December 14, 2007
Androgen receptor expression in prostate cancer stem cells: is there a conundrum?Nima Sharifi, Elaine M Hurt, William L Farrar
Journal of Molecular Endocrinology|November 3, 2007
Transforming growth factor-beta receptor III downregulation in prostate cancer: is inhibin B a tumor suppressor in prostate?Nima Sharifi, Robert J Lechleider, William L Farrar
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
American Journal of Epidemiology|March 18, 2008
Re: "Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the women's health initiative (United States)"Nima Sharifi, William L Farrar
American Journal of Therapeutics|April 29, 2006
Androgen receptor as a therapeutic target for androgen independent prostate cancerNima Sharifi, William L Farrar
Medical Hypotheses|December 21, 2005
Perturbations in hypoxia detection: a shared link between hereditary and sporadic tumor formation?Nima Sharifi, William L Farrar
Molecular Interventions|August 12, 2008
Cancer stem cells: the seeds of metastasis?Elaine M Hurt, William L Farrar
Trends in Immunology|September 9, 2008
Cancer stem cells, CD200 and immunoevasionBrian T Kawasaki, William L Farrar
Epigenomics|November 30, 2011
Cancer stem cell epigenetics and chemoresistanceFrancesco Crea, Romano Danesi, William L Farrar
Biochemistry|April 7, 2004
Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic stateKiranam Chatti, William L Farrar, Roy J Duhé
Molecular Cancer|October 6, 2010
Clinical significance of Polycomb gene expression in brain tumorsFrancesco Crea, Elaine M Hurt, William L Farrar
Cancer Chemotherapy and Pharmacology|December 14, 2007
Androgen receptor expression in prostate cancer stem cells: is there a conundrum?Nima Sharifi, Elaine M Hurt, William L Farrar
Journal of Molecular Endocrinology|November 3, 2007
Transforming growth factor-beta receptor III downregulation in prostate cancer: is inhibin B a tumor suppressor in prostate?Nima Sharifi, Robert J Lechleider, William L Farrar
Pageof 8